製品名:5-Bromo-2-(trifluoromethoxy)aniline

IUPAC Name:5-bromo-2-(trifluoromethoxy)aniline

CAS番号:886762-08-9
分子式:C7H5BrF3NO
純度:98%
カタログ番号:CM118425
分子量:256.02

包装単位 有効在庫 価格(USD) 数量
CM118425-100g in stock ȯŸ
CM118425-500g in stock ƴƴȅ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:886762-08-9
分子式:C7H5BrF3NO
融点:-
SMILESコード:NC1=CC(Br)=CC=C1OC(F)(F)F
密度:
カタログ番号:CM118425
分子量:256.02
沸点:230.2°C at 760 mmHg
MDL番号:MFCD04039242
保管方法:Keep in dark place, store at 2-8°C.

Column Infos

Onvansertib
Polo-like kinase 1 (PLK1) is a key regulator of the cell-cycle progression found in human cancers, and a potential therapeutic target for oncology drug development. The recent journal Clinical Cancer Research details the Phase 1b Study of Onvansertib in combination with chemotherapy+bevacizumab treatment for patients with patients with KRAS-mutated metastatic colorectal cancer (mCRC).
Cardiff Oncology’s novel inhibitor, Onvansertib effectively targets PLK1, that prevents from tumor cell growth. It aids restore DNA damage and promote the efficacy of the standard of care therapy in a number of indications.

Related Products